Public list: Pharma Startups (4729) Cancer Therapeutics (1132)
Efranat develops a unique anti-cancer immunotherapy treatment based on a natural plasma protein molecule named GcMAF. The concept underlying the technology is to engage the body's own immune system and harness it against cancer. GcMAF is a very poten...Show all
Company (Alive / Active)
Phone: + 972 8 9724972
7 Oppenheimer st
Rehovot, 76701
Israel
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Macrophage activating factor for pharmaceutical compositions | Feb 27, 2017 | Application | |
Macrophage activating factor for treating benign or precancerous papillomas | Apr 06, 2016 | Application | |
Macrophage activating factor for pharmaceutical compositions | Sep 02, 2015 | Application | |
Compositions comprising gc-macrophage activating factor and uses thereof | Jun 09, 2014 | Application |